Thromboembolic involvement and its possible pathogenesis in COVID-19 mortality: lesson from post-mortem reports
In conclusion, a complex interaction of SARS-CoV-2 virus invasion with platelets, leukocytes, endothelial cells, inflammation, immune response, and the possible involvement of megakaryocytes may increase the cumulative risk of thrombosis by a yet unclear cellular and humoral interaction.PMID:33629337 | DOI:10.26355/eurrev_202102_24878
Source: European Review for Medical and Pharmacological Sciences - Category: Drugs & Pharmacology Authors: K Dwiputra Hernugrahanto D Novembri Utomo H Hariman N C Budhiparama D Medika Hertanto D Santoso P C W Hogendoorn Source Type: research
More News: Coronavirus | COVID-19 | Drugs & Pharmacology | Lessons | Pandemics | Pulmonary Thromboembolism | Respiratory Medicine | SARS | Study | Thrombocytopenia | Thrombosis